novo nordisk mash - Search News

Order byBest matchMost fresh

News

Novo Nordisk, GLP-1 and Wegovy

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

Continue reading

pharmaphorum · 8h

Novo Nordisk claims first GLP-1 approval in MASH

· 5h · on MSN

Novo Nordisk's Weight-Loss Drug Wegovy Approved to Treat Liver Disease

1h

Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

4don MSN

Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forces

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

4d

The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results